Latest news and press releases about Ekso Bionics Holdings, Inc. (EKSO): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton.
Price
| Price | $15.90 |
| Market Cap | $39M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 9.87 |
| EV / EBITDA | -2.91 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -177.40% |
| Return on Invested Capital | -108.78% |
| Return on Assets | -79.77% |
| Gross Margin | 52.86% |
| Operating Margin | -134.06% |
| Net Margin | -135.66% |
Related companies: AEMD · ALUR · ANL · AYTU · CODX · ERNA · GOVX
Explore sector: Technology · Information Technology Services
More sections of EKSO: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks